DEA Eases Rules for Opioid Recovery Medications
Published Date: 6/9/2026
Rule
Summary
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
No Federal Patient Caps for MAT
Starting July 9, 2026, there is no longer a federal limit on how many patients a practitioner may treat for maintenance or detoxification without separate Narcotic Treatment Program registration. This removes the prior patient-number caps that had limited how many people a single provider could treat.
Pharmacies Can Deliver MAT Drugs to Providers
Pharmacies may deliver certain FDA‑approved Schedule III–V medications for maintenance or detoxification directly to the prescribing or administering practitioner's DEA-registered location for administration to a named patient. This delivery option is intended to help patients get treatment where the practitioner can give the medication directly.
Administration Window Extended to 45 Days
The rule implements the statutory change that a controlled substance delivered by a pharmacy to an administering practitioner must be administered to the named patient within 45 days of receipt (changed from 14 days). This change was made by the Omnibus and is adopted in this final rule.
Administering Practitioner Must Hold Individual DEA Registration
The rule requires that the administering practitioner be individually registered with DEA under 21 U.S.C. 823(g) to dispense and must act within the scope of that registration. DEA declined to expressly list pharmacists as administering practitioners and notes that only in a limited number of states are pharmacists individually registered with DEA to administer controlled substances.
One-Time Training Requirement for Registrants
Under the rule, any qualified practitioner (not solely veterinarians) who first applies for or renews a DEA registration to dispense controlled substances in schedules II–V on or after June 27, 2023, must satisfy a one-time training requirement. The training is a statutory condition of receiving a DEA registration or renewal.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-15199, Kerri Zavota, DVM; Decision and Order
2026-15201, Gene M. Koop, D.D.S.; Decision and Order
2026-14286, Importer of Controlled Substances Application: Catalent Greenville, Inc.
Catalent Greenville, Inc. wants to become an official importer of some powerful controlled substances, including LSD and related drugs. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 17, 2026. This move could impact how these substances enter the U.S., but no costs or fees are mentioned yet.
2026-14137, Shane Lydon, M.D.; Decision and Order
Dr. Shane Lydon's license to handle controlled substances in Maine has been revoked because he lost his state authority and didn’t ask for a hearing. This means he can no longer prescribe or manage these drugs, effective immediately. Anyone relying on his registration should update their records and note this change to avoid legal trouble.
2026-14135, David Enright, M.D.; Decision and Order
Dr. David Enright from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
Previous / Next Documents
Previous: 2026-11513, Schedule of Fees for Consular Services, Department of State and Overseas Embassies and Consulates-Visa and Citizenship Services Fee Changes
Starting July 1, 2026, travelers applying for a B1/B2 business or tourist visa can pay an extra $750 to get a faster interview appointment—within 10 business days—at select U.S. embassies and consulates. This new optional fee is temporary and runs through December 31, 2026. If you want quicker service, be ready to pay up and act fast, as spots are limited!
Next: 2026-11528, Airworthiness Directives; Pilatus Aircraft Ltd. Airplanes
Pilatus PC-12/47E airplane owners need to update their stall warning system software and add a temporary pilot handbook revision by July 14, 2026. This fix stops the stall warning from going off at the wrong times, keeping flights safer. The FAA also bans installing the old, faulty software, so pilots should act fast to avoid any trouble or extra costs.